LONDON: Playing tailor-made videogames can help children with attention deficit hyperactivity disorder (ADHD), according to results from a pivotal clinical trial announced.
The US company developing the treatment, unlisted Akili, now plans to file for regulatory approval with the US Food and Drug Administration in the first half of 2018, paving the way for what would be the first such "digital" prescription product.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
